Acadia 2024 Conference Call. Acadia pharmaceuticals issued q3 2024 earnings on november 6, 2024, reporting an eps of $0.20, which topped the consensus estimate of $0.14 by $0.06. Welcome to the acadia pharmaceuticals second quarter 2024 financial results conference call.

Acadia is trailblazing breakthroughs in neuroscience to elevate life. Acadia will host a conference call to discuss the fourth quarter and full year december 31, 2023 results today, tuesday, february.